- Home
- PRM vs HRMY Comparison
PRM vs HRMY Comparison
Compare PRM & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRM
- HRMY
- Stock Information
- Founded
- PRM 2018
- HRMY 2017
- Country
- PRM United States
- HRMY United States
- Employees
- PRM N/A
- HRMY N/A
- Industry
- PRM Newspapers/Magazines
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- PRM Consumer Discretionary
- HRMY Health Care
- Exchange
- PRM Nasdaq
- HRMY Nasdaq
- Market Cap
- PRM 1.5B
- HRMY 1.6B
- IPO Year
- PRM N/A
- HRMY 2020
- Fundamental
- Price
- PRM $11.61
- HRMY $34.05
- Analyst Decision
- PRM Strong Buy
- HRMY Strong Buy
- Analyst Count
- PRM 2
- HRMY 8
- Target Price
- PRM $16.00
- HRMY $52.88
- AVG Volume (30 Days)
- PRM 879.7K
- HRMY 701.6K
- Earning Date
- PRM 05-08-2025
- HRMY 05-06-2025
- Dividend Yield
- PRM N/A
- HRMY N/A
- EPS Growth
- PRM N/A
- HRMY 13.13
- EPS
- PRM 0.90
- HRMY 2.62
- Revenue
- PRM $573,954,000.00
- HRMY $744,852,000.00
- Revenue This Year
- PRM N/A
- HRMY $20.06
- Revenue Next Year
- PRM $4.89
- HRMY $18.40
- P/E Ratio
- PRM $12.92
- HRMY $13.10
- Revenue Growth
- PRM 70.16
- HRMY 20.62
- 52 Week Low
- PRM $7.00
- HRMY $26.47
- 52 Week High
- PRM $14.44
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- PRM 67.52
- HRMY 69.53
- Support Level
- PRM $10.23
- HRMY $29.82
- Resistance Level
- PRM $10.68
- HRMY $30.61
- Average True Range (ATR)
- PRM 0.38
- HRMY 1.12
- MACD
- PRM 0.16
- HRMY 0.74
- Stochastic Oscillator
- PRM 86.92
- HRMY 92.78
About PRM Perimeter Solutions SA
Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.